 Bronchoalveolar lavage analysis Wegener granulomatosis method disease pathogenesis prospective analysis bronchoalveolar lavage BAL patients Wegener granulomatosis WG disease control idiopathic pulmonary fibrosis IPF normal control subjects quality alveolar inflammatory response active WG determine antineutrophil cytoplasmic antibody ANCA present alveolar fluid lungs patients WG determine inhaled particles infectious agents etiologic role WG BAL untreated active WG marked increase neutrophils mean total WBC count eosinophils mean normal control subjects neutrophils eosinophils untreated WG remission neutrophils eosinophils Disease control IPF process neutrophilic alveolitis population neutrophils BAL Leukocyte remnants intact leukocytes BAL macrophages patients WG IPF normal control subjects Normal subjects control patients IPF negative ANCA serum ANCA serum BAL patients active WG disease Protein analysis BAL disproportionate increase IgG ration serum values IgG index patients active untreated disease increase IgG index IgG ANCA reactivity pulmonary lymphoid tissue infectious agent BAL techniques study